Abstract
Generating a pharmacophore is often the first step towards understanding the interactions between a receptor and a ligand and can be pivotal to a successful drug discovery project. The pharmacophore tools at Accelrys have been used to assist in many different projects over the years, such as lead generation, scaffold hopping, mining ligand databases as well as many more. In this article, we will review the pharmacophore tools that have been developed at Accelrys. These will include the often used and well validated ligand based algorithms, HipHop and HypoGen and as well as extensions of these algorithms, HipHopRefine and HypoGenRefine. Recently we also developed new pharmacophore tools in the area of structure based design – deriving pharmacophores from the receptor as well as the receptor-ligand complex – which will also be discussed in this paper.
Keywords: Fragment-based design, receptor-ligand pharmacophore, structure-based pharmacophore, scaffold hopping, mining ligand databases, algorithms, pharmacophore tools, structure based design, receptor-ligand complex, 2D SAR
Current Computer-Aided Drug Design
Title: New Features that Improve the Pharmacophore Tools from Accelrys
Volume: 7 Issue: 3
Author(s): Jon Sutter, Jiabo Li, Allister J. Maynard, Anne Goupil, Tien Luu and Katalin Nadassy
Affiliation:
Keywords: Fragment-based design, receptor-ligand pharmacophore, structure-based pharmacophore, scaffold hopping, mining ligand databases, algorithms, pharmacophore tools, structure based design, receptor-ligand complex, 2D SAR
Abstract: Generating a pharmacophore is often the first step towards understanding the interactions between a receptor and a ligand and can be pivotal to a successful drug discovery project. The pharmacophore tools at Accelrys have been used to assist in many different projects over the years, such as lead generation, scaffold hopping, mining ligand databases as well as many more. In this article, we will review the pharmacophore tools that have been developed at Accelrys. These will include the often used and well validated ligand based algorithms, HipHop and HypoGen and as well as extensions of these algorithms, HipHopRefine and HypoGenRefine. Recently we also developed new pharmacophore tools in the area of structure based design – deriving pharmacophores from the receptor as well as the receptor-ligand complex – which will also be discussed in this paper.
Export Options
About this article
Cite this article as:
Sutter Jon, Li Jiabo, J. Maynard Allister, Goupil Anne, Luu Tien and Nadassy Katalin, New Features that Improve the Pharmacophore Tools from Accelrys, Current Computer-Aided Drug Design 2011; 7 (3) . https://dx.doi.org/10.2174/157340911796504305
DOI https://dx.doi.org/10.2174/157340911796504305 |
Print ISSN 1573-4099 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6697 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Proteochemometrics for the Prediction of Binding to the MHC Proteins
Letters in Drug Design & Discovery Beyond Cox-Inhibition: ‘Side-Effects’ of Ibuprofen on Neoplastic Development and Progression
Current Pharmaceutical Design Increased Neutrophil-to-lymphocyte Ratios are Associated with Greater Risk of Hemorrhagic Transformation in Patients with Acute Ischemic Stroke
Current Neurovascular Research Distinct Modulation of Wild-Type and Selective Gene Mutated Vitamin D Receptor by Essential Polyunsaturated Fatty Acids
Mini-Reviews in Medicinal Chemistry Mechanisms of Non-Opioid Analgesics Beyond Cyclooxygenase Enzyme Inhibition
Current Molecular Pharmacology Voltage-Gated Calcium Channels as Targets for the Treatment of Chronic Pain
Current Drug Targets - CNS & Neurological Disorders Protein Kinase CK2 in Human Diseases
Current Medicinal Chemistry Hemophagocytic Lymphohistiocytosis (HLH): An Update
Current Immunology Reviews (Discontinued) Risk Factors for Heart Failure Progression and Outcomes
Current Cardiology Reviews Biomolecules of Human Female Fertility - Potential Therapeutic Targets for Pharmaceutical Design
Current Pharmaceutical Design Role of Trim5α in the Suppression of Cross-Species Transmission and its Defence Against Human Immunodeficiency Virus
Current HIV Research Haptoglobin Polymorphisms and Fucosylation Change: Possible Influence of Variation on the Identified Lung Cancer-relevant Biomarkers
Current Proteomics Amniotic Fluid Embolism: Moving Diagnosis Through the Time. From the Mechanical Pulmonary Vascular Occlusion Until An Immuno - Inflammatory Pathogenesis?
Current Pharmaceutical Biotechnology Preeclampsia: Placental Origins, New Predictors and New Therapeutic Strategies
Current Women`s Health Reviews Oligomerization of G Protein-Coupled Receptors: Biochemical and Biophysical Methods
Current Medicinal Chemistry Interleukin-19 as an Immunoregulatory Cytokine
Current Molecular Pharmacology Development of Microemulsion and Niosome Based Transdermal Formulations of Diclofenac Sodium and Comparative <I>In Vitro</i> and <i>Ex Vivo</i> Evaluations with Marketed Products
Drug Delivery Letters Oxidative Stress and the JNK Pathway are Involved in the Development of Type 1 and Type 2 Diabetes
Current Molecular Medicine DNA Vaccine and the CNS Axonal Regeneration
Current Pharmaceutical Design The Role of Host-Cellular Responses in COVID-19 Endothelial Dysfunction
Current Drug Targets